Ascentage Pharma Group International 亞盛醫藥集團
Pay for financial year ended 2024-12-31
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Directors |
||||||||
| 1 | Bozilenko, Marina S | INED | 36 | 36 | ||||
| 2 | Lu, Simon Dazhong 呂大忠 | NED | ||||||
| 3 | Ren, Wei (1980) 任為 | INED | 427 | 52 | 479 | |||
| 4 | Sidransky, David | INED | 427 | 42 | 469 | |||
| 5 | Wang, Shaomeng 王少萌 | NED | 1,178 | 1,178 | ||||
| 6 | Yang, Dajun (1962) 楊大俊 | Ch, CEO, Co-Fdr | 3,917 | 273 | 4,190 | |||
| 7 | Ye, Benjamin Changqing 葉長青 | INED | 427 | 52 | 479 | |||
| 8 | Yin, Zheng (1971) 尹正 | INED | 186 | 52 | 238 | |||
| 9 | Yu, Debra Jiuyun 余久筠 | INED | 36 | 36 | ||||
| Total | 1,539 | 5,095 | 0 | 273 | 198 | 7,105 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1,539 | 5,095 | 0 | 273 | 198 | 7,105 | Report |
| 2023-12-31 | 1,692 | 5,693 | 0 | 253 | 349 | 7,987 | Report |
| 2022-12-31 | 1,616 | 4,891 | 0 | 242 | 1,176 | 7,925 | Report |
| 2021-12-31 | 1,419 | 5,636 | 0 | 181 | 2,016 | 9,252 | Report |
| 2020-12-31 | 1,207 | 5,307 | 0 | 122 | 2,798 | 9,434 | Report |
| 2019-12-31 | 592 | 4,527 | 0 | 128 | 2,663 | 7,910 | Report |
| Total | 8,065 | 31,149 | 0 | 1,199 | 9,200 | 49,613 |
Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy